🏛️ Verified NIH Record • Updated 2026-07-08
Interstitial Lung Disease Research Unit Biobank (NCT05392881)
🟢 Recruiting Interventional Protocol 📊 Observational Clinical Research Sponsor: University of Kansas Medical Center
🩺 Plain-English Summary (8th-Grade Level)
Establish a interstitial lung disease (ILD) registry and biorepository to lead towards a further understanding of the disease.
Who can join: To join this study, participants generally need to meet the listed inclusion criteria (4 items) and avoid the listed exclusions (0 items).
Location: The University of Kansas Medical Center — Kansas City, Kansas
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistCheck every box below. If you can check all of them, you may meet the study's basic screening requirements (final eligibility is confirmed by the site team).
🔍 Extracted verbatim from the official NIH eligibility criteria. Always confirm with the study coordinator.
📍 All Participating Trial Locations (1 Sites)
- The University of Kansas Medical Center — Kansas City, Kansas
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.